Local Institution - 1022-Ph2

Guangzhou, Guangdong 510030

0 studies enrolling now · 1 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now